The Federal Trade Commission and 13 states have sued to block Covetrus’ proposed $3.5 billion acquisition of Cencora’s MWI Animal Health, alleging the transaction would reduce competition in the market for veterinary products and push costs higher for clinics and pet owners.
The complaint was filed under seal Friday in federal court in Manhattan. The lawsuit seeks to stop the merger of two of the country’s largest distributors serving veterinary clinics, according to the FTC and the states. The companies supply products including pharmaceuticals, vaccines, gloves and syringes.
Regulators allege the deal would give the combined company greater control over a concentrated distribution market. They say that could result in higher prices for veterinary practices, which may pass those costs on to customers, as well as weaker service. The complaint also alleges the transaction could reduce the quality of services available to clinics.
“Veterinarians and millions of American pet owners benefit when veterinary distributors compete by offering lower prices and better service,” Daniel Guarnera, director of the FTC’s Bureau of Competition, said in a statement.
What regulators are challenging
The FTC’s case is a challenge to a proposed transaction, not a final finding that the merger violated antitrust law. The agency and the states must establish their allegations in court. A federal judge has not been identified in the material announcing the filing, and the filing was initially sealed.
- Buyer: Covetrus Inc., based in Maine.
- Target: MWI Animal Health, owned by Cencora Inc.
- Transaction value: $3.5 billion.
- States joining the FTC: 13 states, including New York but not Pennsylvania or New Jersey.
New York Attorney General Letitia James said the proposed merger could increase the cost of veterinary care. “A trip to the vet should never break the bank,” James said in a statement. She said pet owners are already paying high prices and that the transaction could add to those costs.
Companies dispute the allegations
Covetrus said the FTC’s case relies on what it called a narrow and outdated view of the market. The company said clinics can obtain products from numerous manufacturers and distributors and that online platforms give veterinarians flexibility in choosing suppliers.
“Clinics today choose freely from numerous manufacturers and distributors to meet their needs, and online platforms have ensured that veterinarians have complete flexibility across a wide range of suppliers,” Covetrus said in a statement.
Cencora, a publicly traded company formerly known as AmerisourceBergen, did not immediately respond to a request for comment, according to the report. Under the proposed deal, Cencora would receive $1.25 billion in cash, $800 million in preferred equity and $1.45 billion in common equity. Cencora would retain a 34% common-equity stake in the combined business.
The FTC and states are asking the court to prevent the acquisition from going forward. The lawsuit adds to the agency’s scrutiny of mergers that regulators say could affect prices and competition in markets serving American consumers.